34 /100
MEDIUM RISK
Score updated Jul 14, 2026

LATA — Galata Acquisition Corp. II Dilution Risk Tracker

Track LATA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LATA — Get alerts when the score changes →

As of July 14, 2026, Galata Acquisition Corp. II (LATA) has a DilutionWatch DilutionScore of 34/100, rated MEDIUM dilution risk. Galata Acquisition Corp. II has a market capitalization of $232.53M, 17.25M shares outstanding, 54 institutional holders tracked. Key dilution vectors include approximately 25 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for LATA.
🔔 Track LATA — Get forecast alerts →

💹 Market Data

Market Cap$232.53M
Shares Outstanding17.25M
Float15.90M
Cash$770.4K
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 11.7% shares (2026Q1 vs prior)
54 institutional holders · 15.61M shares
#1 ADAGE CAPITAL PARTNERS GP, L.L.C. 1.35M shares
#2 PICTON MAHONEY ASSET MANAGEMENT 1000.0K shares
#3 Linden Advisors LP 750.0K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest168
Days to Cover1.0
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for LATA Shareholders

Galata Acquisition Corp. II (LATA) has a DilutionScore of 34/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for LATA shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for LATA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for LATA alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track LATA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LATA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for LATA
📊 LATA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LATA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.